Rock Creek Group, LP Gilead Sciences, Inc. Transaction History

Rock Creek Group, LP

$1.12 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $4,362 - $4,759	59 Added 28.64%	265 $19,000
Q2 2023 Aug 09, 2023	BUY	$76.01 - $86.7 $15,658 - $17,860	206 New	206 $15,000
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $19,443 - $27,914	-312 Reduced 89.14%	38 $3,000
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $139,323 - $159,143	-2,340 Reduced 86.99%	350 $22,000
Q2 2022 Aug 08, 2022	SELL	$57.72 - $65.01 $95,353 - $107,396	-1,652 Reduced 38.05%	2,690 $166,000
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $165,477 - $207,361	2,857 Added 192.39%	4,342 $258,000
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $2,984 - $3,387	46 Added 3.2%	1,485 $108,000
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $67,893 - $73,249	-1,003 Reduced 41.07%	1,439 $101,000
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $13,011 - $14,216	205 Added 9.16%	2,442 $168,000
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $187,740 - $214,211	-3,129 Reduced 58.31%	2,237 $145,000
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $47,132 - $53,705	832 Added 18.35%	5,366 $313,000
Q3 2020 Oct 30, 2020	SELL	$62.1 - $78.08 $132,148 - $166,154	-2,128 Reduced 31.94%	4,534 $287,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $736,927 - $855,708	-10,187 Reduced 60.46%	6,662 $513,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $25,490 - $32,649	407 Added 2.48%	16,849 $1.26 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $1.01 Million - $1.11 Million	16,442 New	16,442 $1.07 Million
Q1 2019 May 10, 2019	SELL	$62.53 - $70.05 $748,546 - $838,568	-11,971 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $59,147 - $77,183	977 Added 8.89%	11,971 $749,000
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $783,652 - $867,646	10,994 New	10,994 $849,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Creek Group, LP with notifications on news.

Account